Market Research Report Store Active Pharmaceutical Ingredients

"Active Pharmaceutical Ingredients/API Market Expected to reach USD 213.97 billion by 2021 from USD 157.95 billion in 2016, growing at a CAGR of 6.3% from 2016 to 2021" published in June 2017. It is a professional and in-depth study. Summary Market Research Report Store announces a new report＂Active Pharmaceutical Ingredients/API Market＂added to its database.The active pharmaceutical ingredients market in terms of value is expected to reach USD 213.97 billion by 2021 from USD 157.95 billion in 2016, growing at a CAGR of 6.3% from 2016 to 2021. This market is categorized on the basis of type, type of manufacturer, type of synthesis, type of drug, therapeutic application, and region. Detailed TOC Of Report @ https://www.marketresearchreportstore.com/shop/active-pharmaceutical-ingredientsapi-market- by-type-innovative-generic-manufacturer-captive-merchant-synthesis-synthetic-biotech-product- mab-hormone-drug-otc-rx-therapy-diabetes-2 Ask a sample, click here [email protected] Major factors contributing to the growth of the active pharmaceutical ingredients market include increasing incidence of chronic diseases, rising prevalence of cancer, technological advancements in API manufacturing, growing importance of generics, rapidly increasing geriatric population, increase in abbreviated new drug applications (ANDA) and increasing uptake of biopharmaceuticals. Government initiatives to encourage adoption of generics also provide an impetus for the growth of this market. For instance, in 2008, the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, launched the Jan Aushadhi Scheme (Public Medicine Scheme) for providing quality medicines to the masses at affordable prices. Under this initiative, the government set up Jan Aushadhi stores to provide generic drugs to patients. Similarly, The European Union’s decentralized procedure (DCP) for drug approval is an effective system for cross-border collaboration on the authorization of medicines. This is being used as a model for a number of new global initiatives in the harmonization of pharmaceutical regulatory standards. The implementation of such standards in turn is expected to drive the adoption of generic drugs. Emerging biosimilars market, increasing scope for HPAPIs, emerging markets and emerging technologies have opened an array of opportunities for the active pharmaceutical ingredients market. However, factors such as a stringent regulatory requirements and unfavorable drug price control policies across various countries may restrain the growth of this market.